Burkhard Blank
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Burkhard Blank formerly worked at Laurantis Pharma Oy, as Chief Executive Officer from 2013 to 2014, RIEMSER Pharma GmbH, as Director, Acorda Therapeutics, Inc., as Head-Drug Safety, Acorda Therapeutics, Inc., as Chief Medical Officer, Head-Research & Development from 2016 to 2021, Mersana Therapeutics, Inc., as Head-Clinical Development & Regulatory Affairs, MannKind Corp., as Chief Medical Officer, EVP-Research & Development from 2023 to 2025, Altus Pharmaceuticals, Inc., as Chief Medical Officer & Executive Vice President from 2006 to 2009, Boehringer Ingelheim Pharmaceuticals, Inc., as SVP-Medicine & Drug Regulatory Affairs from 2001 to 2006, Pharnext SA, as Chief Medical Officer, Head-Research & Development, and Herantis Pharma Oyj, as Chief Medical Officer.
Dr. Blank received his doctorate degree from Philipps University of Marburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MANNKIND CORPORATION 0,15 % | 15/07/2025 | 460 791 ( 0,15 % ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| MANNKIND CORPORATION | Directeur Technique/Scientifique/R&D | 14/05/2025 |
| ACORDA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/12/2021 |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Directeur Général | 01/05/2014 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Directeur Technique/Scientifique/R&D | 27/03/2009 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01/06/2006 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
MannKind Corp.
MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
RIEMSER Pharma GmbH
RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Herantis Pharma Oyj
Herantis Pharma Oyj Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products to treat neurological disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national